Cypress' Science & Technology program is comprised of a number of research initiatives, ranging from the studies into the pathophysiology underlying fibromyalgia (FM) to evaluating new compounds in several clinically important conditions that are presently under consideration by Cypress. The ultimate goals of such initiatives include increasing Cypress' exposure through scientific publications, preparing and supporting patent applications, and testing hypotheses, particularly as they relate to new pharmacology and indications.